⌘K

Login Start Free

Home/Filings/4/0000891293-15-000059

4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-15-000059

CIK 0000891293operating

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:39 PM ET

Size

23.4 KB

Accession

0000891293-15-000059

Insider Transaction Report

Form 4

Period: 2015-11-19

CTI BIOPHARMA CORPctic

EVP, Finance & Administration

Transactions

Sale
Common Stock
2015-11-19$1.15/sh−500$575→ 907,547 total
Sale
Common Stock
2015-11-19$1.16/sh−1,100$1,271→ 906,447 total
Sale
Common Stock
2015-11-19$1.13/sh−1,000$1,125→ 913,147 total
Sale
Common Stock
2015-11-19$1.13/sh−1,200$1,356→ 911,947 total
Sale
Common Stock
2015-11-19$1.14/sh−100$114→ 911,847 total
Sale
Common Stock
2015-11-19$1.14/sh−806$919→ 911,041 total
Sale
Common Stock
2015-11-19$1.15/sh−2,994$3,428→ 908,047 total
Sale
Common Stock
2015-11-19$1.16/sh−100$116→ 906,347 total
Sale
Common Stock
2015-11-19$1.10/sh−800$880→ 920,547 total
Sale
Common Stock
2015-11-19$1.10/sh−1,400$1,547→ 919,147 total
Sale
Common Stock
2015-11-19$1.11/sh−3,800$4,218→ 915,347 total
Sale
Common Stock
2015-11-19$1.11/sh−200$223→ 915,147 total
Sale
Common Stock
2015-11-19$1.12/sh−1,000$1,120→ 914,147 total

Holdings

Common Stock
(indirect: By Trust)
37

Footnotes (1)

[F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000891293

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 5:39 PM ET
Size: 23.4 KB

View on SEC.gov